Abstract
ABSTRACTGlutaminolysis, the metabolic process of converting glutamine into key intermediates, plays an essential role in cellular energy production, signaling, biosynthesis, and redox balance. Deregulation of glutamine metabolism significantly influences various pathological conditions, including cancers and metabolic and neurological diseases. Emerging evidence shows that long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and oncogenic alterations in glutamine transporters and enzymes enhance glutamine's role as an alternative energy source, supporting cell survival and proliferation under nutrient and oxygen deprivation conditions. To combat the pathogenic effects of altered glutamine metabolism, researchers are developing targeted inhibitors of key enzymes and transporters involved in glutaminolysis. By interfering with the mechanisms that support the growth of cancer cells, these inhibitors may be able to stop the growth of tumors and treat metabolic and neurological conditions. This review provides a comprehensive overview of existing inhibitors and ongoing clinical trials targeting glutamine metabolism, focusing on its potential as a cancer therapeutic strategy. Additionally, the role of lncRNAs and circRNAs in regulating glutamine metabolism is explored, revealing novel avenues for therapeutic intervention in cancer and other diseases.
Topics

No keywords indexed for this article. Browse by subject →

References
399
[1]
The hallmarks of cancer metabolism: Still emerging

Natalya N. Pavlova, Jiajun Zhu, Craig B. Thompson

Cell Metabolism 10.1016/j.cmet.2022.01.007
[4]
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden, Lewis C. Cantley, Craig B. Thompson

Science 10.1126/science.1160809
[6]
[11]
Glutaminolysis: A Hallmark of Cancer Metabolism

Lifeng Yang, Sriram Venneti, Deepak Nagrath

Annual Review of Biomedical Engineering 10.1146/annurev-bioeng-071516-044546
[26]
mTOR Signaling in Growth Control and Disease

Mathieu Laplante, David M. Sabatini

Cell 10.1016/j.cell.2012.03.017
[27]
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

Paul Nicklin, Philip Bergman, Bailin Zhang et al.

Cell 10.1016/j.cell.2008.11.044
[28]
Ziello J. E. "Hypoxia‐Inducible Factor (HIF)‐1 Regulatory Pathway and Its Potential for Therapeutic Intervention in Malignancy and Ischemia" The Yale Journal of Biology and Medicine (2007)
[31]
The hallmarks of cancer

Tony Gutschner, Sven Diederichs

RNA Biology 10.4161/rna.20481
[41]

Showing 50 of 399 references

Metrics
24
Citations
399
References
Details
Published
Jun 25, 2025
Vol/Issue
6(7)
License
View
Authors
Funding
Indian Council of Medical Research Award: IDNo.2022‐16465
Cite This Article
Mudasir A. Kumar, Sana Khurshid Baba, Inamu Rashid Khan, et al. (2025). Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases. MedComm, 6(7). https://doi.org/10.1002/mco2.70120